ArticleJournal of global oncology2017

Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor-Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint.

Ettienne J Myburgh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.